research use only
Cat.No.S4224
|
In vitro |
DMSO
: 24 mg/mL
(196.52 mM)
Water : 24 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 122.12 | Formula | C4H10O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 149-32-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | meso-Erythritol | Smiles | C(C(C(CO)O)O)O | ||
| In vitro |
Erythritol is a four-carbon sugar alcohol (polyol) that has a sweetness 60 to 80% that of sucrose and is intended for use in food principally as a low-calorie sweetener. This compound administered orally is rapidly absorbed from the gastrointestinal tract. It is not systemically metabolized and is rapidly excreted unchanged in the urine. |
References |
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT03986476 | Completed | IBS |
Örebro University Sweden |
March 26 2019 | Not Applicable |
| NCT03624569 | Unknown status | Cardiovascular Diseases|Endotoxemia|Endothelial Dysfunction|Postprandial Hyperglycemia|Gut Health |
Ohio State University|Alliance for Potato Research and Education |
August 15 2018 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.